The Top Line Inside ASCO 2025: Big data drops and a towering campaign
Jun 6, 2025
Angus Liu, a journalist from Fierce Pharma specializing in the pharmaceutical industry, explores the highlights from the ASCO 2025 meeting. He dissects the exciting phase 3 data on Enhertu for breast cancer from AstraZeneca and Daiichi Sankyo. Angus also delves into Johnson & Johnson’s striking ‘Breathtaking’ campaign for lung cancer, showcased from the stunning heights of Chicago's Willis Tower. Discover groundbreaking biotech developments and unique insights from the ASCO exhibit hall that could change cancer treatment dynamics.
AI Snips
Chapters
Transcript
Episode notes
J&J's Breathtaking Campaign Event
- Johnson & Johnson highlighted their Ribrovant-Lazcluze lung cancer combo with a "Breathtaking Moments" event at the Willis Tower's 99th floor.
- The campaign celebrated life beyond lung cancer alongside a stunning Chicago skyline view.
Genentech's Massive ASCO Booth
- Genentech had the largest booth at ASCO 2025, spanning nearly 10,000 square feet.
- Other companies had large booths too, but none as extensive as Genentech's this year.
Striking Booth Designs at ASCO
- AMD Serona’s alien-themed vibrant booth and ESA’s garden-themed colorful display stood out at the ASCO exhibit hall.
- These creative exhibits caught the eyes of attendees and added visual interest to the event.